Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation
J S Stenehjem; K B Smeland; K Murbraech; H Holte; S Kvaløy; T Wethal; C E Kiserud; M B Lund
Author Information: Department of Oncology, National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.